← Back to feed
Business1 event
Dr. Reddy’s to roll out Takeda’s dengue vaccine in India
- 📣announcement
Dr. Reddy's Laboratories secures exclusive rights to commercialize Takeda's Qdenga vaccine in India
Dr. Reddy's Laboratories has entered into a strategic partnership with Takeda Pharmaceutical to bring the Qdenga dengue vaccine to the Indian market. Company executives confirmed that commercial rollout is slated for the first half of 2027, making it the country's first approved vaccine against the disease. Investors responded positively to the announcement, pushing Dr. Reddy's stock higher during trading sessions.
Google News India — Top ↗